Titan Medical Inc.
TMDI · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $20,093 | $20,000 | $0 | $0 |
| % Growth | 0.5% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $58 | $0 |
| Gross Profit | $20,093 | $20,000 | -$58 | $0 |
| % Margin | 100% | 100% | – | – |
| R&D Expenses | $37,955 | $7,937 | $51,418 | $32,858 |
| G&A Expenses | $12,426 | $7,488 | $7,815 | $6,803 |
| SG&A Expenses | $12,426 | $7,629 | $7,815 | $6,803 |
| Sales & Mktg Exp. | $0 | $141 | -$0 | $0 |
| Other Operating Expenses | $699 | $0 | $33 | $29 |
| Operating Expenses | $51,080 | $15,566 | $59,265 | $39,690 |
| Operating Income | -$14,677 | -$23,093 | -$41,484 | -$22,639 |
| % Margin | -73% | -115.5% | – | – |
| Other Income/Exp. Net | $16,185 | -$1,091 | $10,802 | $0 |
| Pre-Tax Income | -$14,802 | -$24,185 | -$41,907 | -$22,639 |
| Tax Expense | $56 | $1,091 | $423 | $0 |
| Net Income | -$14,858 | -$25,276 | -$42,330 | -$22,639 |
| % Margin | -73.9% | -126.4% | – | – |
| EPS | -0.22 | -0.38 | -1.38 | -1.36 |
| % Growth | 42.1% | 72.5% | -1.5% | – |
| EPS Diluted | -0.22 | -0.38 | -1.38 | -1.36 |
| Weighted Avg Shares Out | 67,009 | 67,009 | 30,690 | 16,635 |
| Weighted Avg Shares Out Dil | 67,009 | 67,009 | 30,690 | 16,635 |
| Supplemental Information | – | – | – | – |
| Interest Income | $73 | $29 | $116 | $288 |
| Interest Expense | $125 | $1,091 | $423 | $0 |
| Depreciation & Amortization | $699 | $237 | $33 | $29 |
| EBITDA | -$13,978 | -$22,857 | -$41,452 | -$22,610 |
| % Margin | -69.6% | -114.3% | – | – |